| Literature DB >> 32678131 |
Youngsub Eom1,2, Kyung Sun Na3,2, Ho Sik Hwang3,2, Kyong Jin Cho4,2, Tae-Young Chung5,2, Roo Min Jun6,2, Byung Yi Ko7,2, Yeoun Sook Chun8,2, Hyun Seung Kim9,2, Jong Suk Song10,11.
Abstract
The purpose of this randomized clinical trial is to evaluate the effect of eyelid hygiene on subjective symptoms, anterior blepharitis, and meibomian gland dysfunction (MGD) after cataract surgery. Subjects with obstructive MGD who underwent cataract surgery were randomly divided into two groups. In the eyelid hygiene group, eyelid hygiene was performed twice a day for 10 days from 3 days before to 1 week after cataract surgery. The control group did not perform eyelid hygiene. A subjective symptom questionnaire of SPEED, anterior blepharitis grade, and meibum quality and quantity was evaluated at baseline and at postoperative 1 and 4 weeks. The eyelid hygiene group (n = 36) showed decreased SPEED score after cataract surgery and the control group (n = 33) did not. Anterior blepharitis grade was worse 1 week after surgery in the control group but not in the eyelid hygiene group. The control group had significantly decreased meibum quality and quantity in both the upper and lower eyelids after cataract surgery, but the eyelid hygiene group did not. Eyelid hygiene before/after cataract surgery improved postoperative subjective symptoms and prevented postoperative exacerbation of anterior blepharitis and MGD. Thus, perioperative eyelid hygiene is recommended for patients with obstructive MGD who undergo cataract surgery.Entities:
Mesh:
Year: 2020 PMID: 32678131 PMCID: PMC7366917 DOI: 10.1038/s41598-020-67888-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of a randomized controlled pilot trial on clinical efficacy of eyelid hygiene in blepharitis and meibomian gland cataract surgery. TASS = toxic anterior segment syndrome. Figure was created by Microsoft PowerPoint 2016.
Figure 2Comparison of subjective symptom scores between control and eyelid hygiene groups. The Standard Patient Evaluation of Eye Dryness Questionnaire (SPEED) was used to assess patient subjective symptoms and yields a score from 0 to 28. A score of 0 is the best score, and a score of 28 is the worst score. Asterisk indicates a P value < .05 by the repeated measures ANOVA with a Bonferroni correction. Figure was created by IBM SPSS Statistics Standard 20 and Microsoft PowerPoint 2016.
Figure 3Comparison of ocular surface staining score and tear break-up time between control and eyelid hygiene groups. (A) Ocular surface staining score. (B) Tear break-up time. Asterisk indicates a P value < .05 by the repeated measures ANOVA with a Bonferroni correction. Figures were created by Microsoft PowerPoint and Excel 2016.
Comparison of anterior blepharitis and inflammatory signs between control and eyelid hygiene groups.
| Control | Eyelid Hygiene | ||
|---|---|---|---|
| Eyelid debris grade (0–4) | |||
| Baseline | 0.7 ± 0.7 | 0.8 ± 0.8 | 0.584 |
| Postop 1 week | 1.2 ± 0.9 | 0.6 ± 0.6 | |
| Postop 4 weeks | 1.0 ± 0.9 | 0.6 ± 0.7 | 0.090 |
| Baseline vs. postop 1 week | 0.547 | ||
| Baseline vs. postop 4 weeks | 0.144 | 0.513 | |
| Postop 1 week vs. 4 weeks | 0.207 | > 0.999 | |
| Eyelid redness/swelling grade (0–4) | |||
| Baseline | 0.9 ± 0.6 | 0.9 ± 0.7 | 0.750 |
| Postop 1 week | 1.1 ± 0.8 | 0.6 ± 0.7 | |
| Postop 4 weeks | 1.0 ± 0.7 | 0.7 ± 0.7 | 0.150 |
| | |||
| Baseline vs. postop 1 week | 0.146 | ||
| Baseline vs. postop 4 weeks | > 0.999 | 0.146 | |
| Postop 1 week vs. 4 weeks | 0.707 | 0.666 | |
| Telangiectasia grade (0–3) | |||
| Baseline | 1.1 ± 0.7 | 1.1 ± 0.7 | 0.844 |
| Postop 1 week | 1.4 ± 0.9 | 1.0 ± 0.8 | 0.063 |
| Postop 4 weeks | 1.3 ± 0.8 | 1.1 ± 0.7 | 0.317 |
| | |||
| Baseline vs. postop 1 week | > 0.999 | ||
| Baseline vs. postop 4 weeks | 0.194 | > 0.999 | |
| Postop 1 week vs. 4 weeks | 0.365 | 0.690 |
SD standard deviation.
* Repeated measures ANOVA with Bonferroni correction.
Comparison of meibomian gland expressibility between control and eyelid hygiene groups.
| Control | Eyelid Hygiene | ||
|---|---|---|---|
| Upper gland expressibility (n/8) | |||
| Baseline | 5.8 ± 2.0 | 5.2 ± 2.7 | 0.339 |
| Postop 1 week | 4.8 ± 2.3 | 6.1 ± 2.1 | |
| Postop 4 weeks | 4.8 ± 2.2 | 5.8 ± 2.2 | 0.053 |
| | |||
| Baseline vs. postop 1 week | 0.072 | ||
| Baseline vs. postop 4 weeks | 0.222 | ||
| Postop 1 week vs. 4 weeks | > 0.999 | 0.496 | |
| Lower gland expressibility (n/8) | |||
| Baseline | 4.4 ± 2.4 | 3.8 ± 2.9 | 0.374 |
| Postop 1 week | 3.1 ± 2.6 | 4.5 ± 2.7 | |
| Postop 4 weeks | 3.3 ± 2.4 | 4.4 ± 2.7 | 0.078 |
| | |||
| Baseline vs. postop 1 week | 0.058 | ||
| Baseline vs. postop 4 weeks | 0.273 | ||
| Postop 1 week vs. 4 weeks | > 0.999 | > 0.999 |
SD standard deviation.
* Repeated measures ANOVA with Bonferroni correction.
Comparison of meibomian gland secretion score between control and eyelid hygiene groups.
| Control | Eyelid Hygiene | ||
|---|---|---|---|
| Upper gland secretion score (0–3) | |||
| Baseline | 1.0 ± 0.8 | 1.2 ± 1.0 | 0.485 |
| Postop 1 week | 1.5 ± 1.0 | 1.1 ± 0.9 | 0.071 |
| Postop 4 weeks | 1.5 ± 1.0 | 1.2 ± 1.0 | 0.154 |
| Baseline vs. postop 1 week | > 0.999 | ||
| Baseline vs. postop 4 weeks | > 0.999 | ||
| Postop 1 week vs. 4 weeks | > 0.999 | > 0.999 | |
| Lower gland secretion score (0–3) | |||
| Baseline | 1.3 ± 1.0 | 1.4 ± 1.1 | 0.936 |
| Postop 1 week | 1.7 ± 1.1 | 1.5 ± 1.2 | 0.457 |
| Postop 4 weeks | 1.7 ± 1.0 | 1.4 ± 1.1 | 0.240 |
| | |||
| Baseline vs. postop 1 week | > 0.999 | ||
| Baseline vs. postop 4 weeks | > 0.999 | ||
| Postop 1 week vs. 4 weeks | > 0.999 | > 0.999 |
SD standard deviation.
*Repeated measures ANOVA with Bonferroni correction.
Figure 4Comparison of meibomian gland loss grade in upper and lower eyelids between control and eyelid hygiene groups. (A) Upper meibomian gland loss. (B) Lower meibomian gland loss. Figures were created by Microsoft PowerPoint and Excel 2016.